2022 Programme Committee & Themes


The 2022 World Cancer Congress programme is built across six themes. They provide the framework through which the global cancer community will be invited to deliver a suite of innovative and interactive sessions covering the full spectrum of cancer control. 



The 2022 World Cancer Congress programme is led by Drs Heather Bryant, Anil D'Cruz, and Pierre-Yves Dietrich.

Heather Bryant

Heather Bryant

Dr Heather Bryant is an Expert Advisor to the Canadian Partnership Against Cancer, and a Clinical Professor at, Department of Oncology, University of Calgary. She initially joined the Partnership in January 2008 as its first Vice President, Cancer Control.

In that role, she developed and led a portfolio of pan-Canadian cancer control programs throughout the cancer continuum, including population-based prevention and cancer screening, diagnosis and care, patient-centred reporting and palliative care, and research (including the launching of the Canadian Partnership for Tomorrow Project).


Read more


Anil D'Cruz

Anil D'Cruz

30 years as an oncologist, current Director at Oncology Apollo Hospitals, Ex-director at Tata Memorial Hospital, Mumbai, India, researcher, administrator and crusader in the field of cancer control and currently serving as President of UICC.

Anil has held leadership positions both nationally and internationally on the Board of Directors/ governing council/ executive committee of numerous hospitals, governmental organisations, cancer care organisations, advocacy groups & professional bodies.


Read more


Pierre-yves dietrich

Pierre-Yves Dietrich

Dr Pierre-Yves Dietrich is full professor at the Faculty of Medicine of the University of Geneva and chairman of the Department of Oncology at the Geneva University Hospitals. He is co-director of the Swiss Cancer Center Léman (SCCL).

Pierre-Yves Dietrich obtained his Advanced Federal Diploma of Higher Education in Medicine from the University of Geneva in 1982, and his doctorate in 1986. After training in internal medicine, he decided to specialize in haematology-oncology in Geneva and at the Institut Gustave Roussy (IGR) in France. In 1991, he obtained a degree in immunopathology at the Institut Pasteur in France and became co-head of the IGR Unit of Immunotherapy. In 1993, he returned to the Geneva University Hospitals and founded the Laboratory of Tumor Immunology with a focus on brain tumor immunology. His research group is providing innovative work in this area, paving the way for the clinical development of therapeutic vaccines and T-cell therapy for patients suffering from brain tumours. For more than 30 years, he has been active both as a clinician and researcher, promoting interactions between biologists and physicians to build translational medicine.

Read more


2022 World Cancer Congress Themes & CO-CHAIRS

1. PREVENTION, screening & early detection

Partha Basu
 Head, Screening Group, Early Detection&Prevention Section, Agency for Research on Cancer (IARC), France
Ophira Ginsburg
Director, High-Risk Cancer Genetics Program, Perlmutter cancer centre, NYU Langone Health, United-States

In this room, the programme will explore primary prevention, including health promotion, examples of best practices in new evidence-based prevention strategies, and vaccines. Exposure to environmental risk factors unhealthy environments will be included, as well as new areas of development in policy, programme management, communications, and education.

Theme's topics of interest


2. cancer research & Progress 

Lisa Stevens
Lisa Stevens
Director, Division of Programme of Action for Cancer Therapy, International Atomic Energy Agency (IAEA), Austria
David Collingridge.png
David Collingridge
Editor-in-chief, The Lancet Oncology, Publishing Director, The Lancet Group, United Kingdom

The programme in this theme will be curated to highlight recent scientific and clinical advances in aetiology, prevention, diagnosis, and treatment of cancer, with a particular focus on post-pandemic recovery. What lessons were learned during the COVID-19 pandemic and what research was done to help cancer health systems regain lost ground and strengthen provision to address the cancer burden in the future? What practices were implemented during the pandemic and what evidence was collected to support modifying the delivery of care? What new modalities or treatment algorithms were proven to have greater efficacy or effectiveness and could have an enduring legacy to overcome inequalities and inequities in cancer care. Topics in these sessions will showcase scientific, translational, clinical, and technological advancements alongside Implementation science and behavioural research.

Theme's topics of interest


3. healthcare systems & policies

David Currow
Professor of Palliative Medicine at ImPACCT, Faculty of Health, University of Technology Sydney, Australia
James Hospedales
Chair, Defeat-NCD Partnership Executive Committee, Port-of-Spain, Trinidad and Tobago

The programme of this room adds value by channelling intellectual effort, collaborations, access to shared resources to stimulate dialogue about implementing global commitments at a national level, as well as strengthen national, regional and local health systems and guiding quality improvement across different aspects of sustainable development, policy and planning, infrastructure, measurement, reporting and performance. 

Theme's topics of interest


4. cancer treatment & palliative care

Stephen Connor.png
Stephen R.Connor
Executive Director, Worldwide Hospice Palliative Care Alliance (WHPCA), United Kingdom
Carlos Rodriguez-Galindo.png
Carlos Rodriguez-Galindo
Director and Executive President, International Outreach Program, St Jude Children's Hospital, United-States

The programme of this room should examine novel interventions to support patient engagement and survivorship in a variety of cancer care delivery settings. It focuses on patient experience and quality of outcome, exploring patient and family engagement, wrestles with rights and expectations of cancer patients and their families and the challenges of access, fairness and consistency of experience and care. It will explore the role of complimentary therapies, identify experiences with alternative treatments and invite challenging discussions about balance of investment and patient power. It invites exploration of measurement issues, prioritisation of service delivery, communication skills of health care professionals, tools to drive health care facility culture and survivorship. Fundamental questions around palliative care, pain relief and end of life issues are invited. 

Theme's topics of interest


5. tobacco control

Todd Harper
Chief Executive Officer, Cancer Council Victoria, Australia
Leslie Rae Ferat
Executive director, Framework Convention Alliance for Tobacco Control (FCA), Switzerland

The programme of this room should examine The WHO Framework Convention on Tobacco Control (WHO FCTC) and its guidelines providing the foundation for countries to implement and manage tobacco control.

Theme's topics of interest


6. people living with cancer

Jacqueline Daly.png
Jacqueline Daly
Secretary to the Board, European Cancer Patient Coalition, Ireland
Kwanele Asante-Shongwe.png
Kwanele Asante-Shongwe
Lawyer, and Former Chairperson, Ministerial Advisory Committee on Cancer Prevention and Control, South Africa


The programme of this room aims to; integrate the patient voices through experiences and best practices sharing, examine the critical role of patient support programmes, and the organisation of patient support groups including the specific challenges met in developing and maintaining their activities for patients, their relatives and caregivers. 

Theme's topics of interest


Wednesday, July 7, 2021